15 years in the making, Marinus Pharmaceuticals’ first FDA-approved product hits shelves


The product was approved to treat seizure disorders in certain epilepsy patients.

Previous Kaleida's new CEO makes leadership changes
Next Zero Irving’s newest tenant: Sequoia Capital